Your browser doesn't support javascript.
SARS-COV-2 Vaccines: What Indicators are Associated with the Worldwide Distribution of the First Doses.
Sobral, Marcos Felipe Falcão; Bezerra de Oliveira, Brigitte Renata; Gomes da Penha Sobral, Ana Iza; Monteiro Marinho, Marcelo Luiz; Duarte, Gisleia Benini; de Souza Melo, André.
  • Sobral MFF; Departamento de Administração, 67744Federal Rural University of Pernambuco, Recife, Brazil.
  • Bezerra de Oliveira BR; Departamento de Administração, 67744Federal Rural University of Pernambuco, Recife, Brazil.
  • Gomes da Penha Sobral AI; Departamento de Psicologia Cognitiva, 28116Federal University of Pernambuco, Recife, Brazil.
  • Monteiro Marinho ML; Departamento de Computação, 67744Federal Rural University of Pernambuco, Recife, Brazil.
  • Duarte GB; Departamento de Economia, 67744Federal Rural University of Pernambuco, Recife, Brazil.
  • de Souza Melo A; Departamento de Economia, 67744Federal Rural University of Pernambuco, Recife, Brazil.
Inquiry ; 58: 469580211060184, 2021.
Article in English | MEDLINE | ID: covidwho-1538023
ABSTRACT
The present study aimed to identify the factors associated with the distribution of the first doses of the COVID-19 vaccine. In this study, we used 9 variables human development index (HDI), gross domestic product (GDP per capita), Gini index, population density, extreme poverty, life expectancy, COVID cases, COVID deaths, and reproduction rate. The time period was until February 1, 2021. The variable of interest was the sum of the days after the vaccine arrived in the countries. Pearson's correlation coefficients were calculated, and t-test was performed between the groups that received and did not receive the immunizer, and finally, a stepwise linear regression model was used. 58 (30.4%) of the 191 countries received the SARS-CoV-2 vaccine. The countries that received the most doses were the United States, China, the United Kingdom, and Israel. Vaccine access in days showed a positive Pearson correlation HDI, GDP, life expectancy, COVID-19 cases, deaths, and reproduction rate. Human development level, COVID-19 deaths, GDP per capita, and population density are able to explain almost 50% of the speed of access to immunizers. Countries with higher HDI and per capita income obtained priority access.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Inquiry Year: 2021 Document Type: Article Affiliation country: 00469580211060184

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Experimental Studies / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Inquiry Year: 2021 Document Type: Article Affiliation country: 00469580211060184